← Back to home
Comparison · Analytics

logrx vs Tplyr

A side-by-side editorial comparison of logrx and Tplyr — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:pharmaverseclinical-trialsr-package

logrx vs Tplyr: at a glance

FeaturelogrxTplyr
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themespharmaverse, logging, clinical-trials, complianceclinical-trials, tables, traceability, r-package
Last editorial update5h ago58m ago
WebsiteVisit →Visit →

What is logrx?

A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.

logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.

Read the full logrx trajectory →

What is Tplyr?

Tplyr made clinical summary tables explain where every number came from.

Tplyr builds clinical summary tables through a layered grammar — count, descriptive statistics, and shift layers assembled onto a table object. The 1.0.0 release added a traceability metadata framework that lets a user ask which source rows produced any given cell, and later releases extended it to cases the first pass missed. The package is maintained by Atorus within the pharmaverse ecosystem.

Read the full Tplyr trajectory →

logrx vs Tplyr: editorial side-by-side

L
logrx
ANALYTICS
0.0

A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.

◆ Current state

logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.

◆ Where it's heading

Feature work concentrated in the 0.1 line — return codes, a results writer, a to_report parameter, and logging of unapproved package and function use — and the 0.2 releases have been compatibility maintenance and hotfixes. Three years of silence in a pharmaverse that has otherwise kept shipping suggests the package reached the shape its users needed rather than that it was abandoned mid-design.

◆ Prediction

Nothing in these entries points to planned work; the likeliest trigger for a release is a breaking change in tidyverse dependencies, which is what produced the last one.

T
Tplyr
ANALYTICS
0.0

Tplyr made clinical summary tables explain where every number came from.

◆ Current state

Tplyr builds clinical summary tables through a layered grammar — count, descriptive statistics, and shift layers assembled onto a table object. The 1.0.0 release added a traceability metadata framework that lets a user ask which source rows produced any given cell, and later releases extended it to cases the first pass missed. The package is maintained by Atorus within the pharmaverse ecosystem.

◆ Where it's heading

Post-1.0 work has been about completing the metadata story and filling gaps in layer composition rather than adding table types — metadata for missing subjects, add_anti_join(), missing-subject rows, data limiting, and fixes to nested count layers where an inner value appears under several outer groups. Releases cluster tightly after a major version, then go quiet, and the window ends with a patch issued days after the release it corrects.

◆ Prediction

Further releases will most likely continue closing traceability and nested-layer edge cases rather than introducing new layer types, following the pattern of both post-1.0 feature releases.

Alternatives to logrx and Tplyr

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either logrx or Tplyr.

See all logrx alternatives → · See all Tplyr alternatives →

Recent activity from logrx and Tplyr

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 2y agoTplyrMissing-subject metadata, add_anti_join(), and nested-layer fixes
  2. 3y agologrxAlignment with tidyselect and dplyr changes
  3. 3y agologrxRelease v0.2.1
  4. 3y agoTplyrMetadata vignette fix and parenthesis hugging
  5. 3y agoTplyrDenominator logic fix ahead of CRAN release
  6. 3y agoTplyrReverse-dependency fix
  7. 3y agoTplyr1.0.0 introduces the traceability metadata framework
  8. 3y agologrxFormatted log output plus CRAN readiness work
  9. 4y agologrxPackage renamed to logrx; return codes and results writer land

Frequently asked questions

What is the difference between logrx and Tplyr?

Both compete on the same themes — pharmaverse, clinical-trials, r-package — within Analytics. logrx and Tplyr are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is logrx better than Tplyr?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. logrx and Tplyr are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to logrx?

Top logrx alternatives in Analytics are ranked by recent ship velocity. Browse the "logrx alternatives" section above for the current picks, or visit /alternatives/logrx for the full list with editorial commentary on each.

What are the best alternatives to Tplyr?

Top Tplyr alternatives in Analytics are ranked by recent ship velocity. Browse the "Tplyr alternatives" section above for the current picks, or visit /alternatives/tplyr for the full list with editorial commentary on each.